Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Given to newborns at birth and to reverse warfarin. | Classic blood thinner monitored by INR tests. |
| Body system | Vitamins & Minerals | Blood & Clotting |
| Drug class | Vitamins | Vitamin K antagonists |
| Supply | Prescription onlyWHO essential medicine | Prescription onlyWHO essential medicine |
| Main uses | Newborn vitamin K deficiency bleeding prevention, Reversing warfarin, Vitamin K deficiency | Atrial fibrillation stroke prevention, Deep vein thrombosis and pulmonary embolism, Mechanical heart valves |
| How it works | Gives the liver what it needs to make clotting proteins. | Stops the liver using vitamin K to make clotting proteins. |
| Starts working | 6–12 hours (IV) | Full effect takes 3–5 days |
| Half-life | — | 20–60 hours (average ~40) |
| Typical adult dose | Warfarin reversal: 1–10 mg by mouth or IV depending on INR and bleeding. | Individual — adjusted to keep INR usually between 2 and 3 (higher for some valves). |
| Forms | Injection, Oral solution | Tablet (colour-coded strengths) |
| Common side effects | Injection discomfort | Bruising, Nosebleeds, Bleeding gums |
| Serious side effects | Severe allergic reaction with fast IV injection (rare) | Major bleeding (blood in urine or stool, vomiting blood, severe headache), Skin necrosis (rare) |
| Don't take if | — | Pregnancy (especially first trimester); Active bleeding or severe bleeding risk; Severe liver disease; Recent major surgery or stroke with bleeding |
| Alcohol | — | Best to limit. Binge drinking changes INR unpredictably and increases bleeding risk; keep intake modest and consistent. |
| Pregnancy | Generally considered safeSafe. | Usually avoidedCauses birth defects in the first trimester; heparin is used instead. |
| Breastfeeding | — | Generally considered safeSafe while breastfeeding. |
| In use since | 1943 | 1954 |
| Brand names | United States: AquaMephyton, MephytonUnited Kingdom: Konakion MMAustralia: Konakion | United States: Coumadin, JantovenUnited Kingdom: MarevanIndia: Warf, Uniwarfin |
| Legal status | — | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | B02BA01 | B01AA03 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker